PROVIDER PROFILE · NPI 1487677043
Julie KrutiakMD
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,555
Unique beneficiaries
—
Total services
3,193
Distinct HCPCS
22
Medicare payment
$80K
Peer benchmark
Total Medicare services vs. 360 Hematology-Oncology providers in MA — top quintile (cohort median 624).
PRESCRIBING · PART D · 2024
Total Rx claims
458
Beneficiaries
—
Total drug cost
$1.3M
Distinct drugs
16
Brand share
29.5%
Top prescribed drugs
Anastrozole114 claims
Hydroxyurea85 claims
Acyclovir41 claims
Apixaban36 claims
Tamoxifen Citrate24 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
REFERRAL NETWORK
Where Julie Krutiak's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 1 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Quest Diagnostics Massachusetts Llc Clinical Laboratory · Marlborough, MA | 26 | 107 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 38 | 156 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE